Silymarin inhibits the lipogenic pathway and reduces worsening of non-alcoholic fatty liver disease (NAFLD) in mice.
Arch Physiol Biochem
; : 1-15, 2022 Nov 03.
Article
in En
| MEDLINE
| ID: mdl-36328030
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Arch Physiol Biochem
Journal subject:
BIOQUIMICA
/
FISIOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Brazil
Country of publication:
United kingdom